Weekly 5-fluorouracil plus cisplatin for
β
Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C
π
Article
π
2009
π
John Wiley and Sons
π
English
β 160 KB
## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5βfluorouracil (5βFU) and cisplatin has increased acute toxicities as well as survival. Onceβweekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we